No. of Pages: 120 | Report Code: TIPRE00014170 | Category: Life Sciences
La terapia antivirale è uno dei rami più interessanti della virologia. Queste terapie si basano su diverse strategie: gli antivirali ad azione diretta prendono di mira le proteine virali, gli enzimi o gli acidi nucleici; gli anticorpi passivi neutralizzano i virus circolanti; e molti altri antivirali prendono di mira le proteine cellulari o i processi essenziali per la replicazione virale.
L\'anti-virus europeo Si prevede che il mercato delle terapie virali raggiungerà i 21.122,66 milioni di dollari entro il 2027 dagli 11.401,67 milioni di dollari del 2019. Si prevede che il mercato crescerà a un CAGR dell\'8,1% nel periodo dal 2020 al 2027. La crescita del mercato è attribuita alla crescente prevalenza di malattie virali e allo scoppio della pandemia di COVID-19, all’aumento delle spese di ricerca e sviluppo da parte delle aziende farmaceutiche e al crescente sostegno del governo alle attività di ricerca e agli studi clinici. Tuttavia, i costi elevati di sviluppo dei farmaci ostacolano in una certa misura la crescita del mercato.
In in termini di tipologia, nel 2019 il segmento dei farmaci di marca ha rappresentato una quota maggiore del mercato europeo delle terapie antivirali. In termini di meccanismo d\'azione, il segmento degli inibitori nucleotidici della polimerasi ha rappresentato la quota maggiore del mercato nel 2019. In termini di applicazione, il segmento dell\'HIV ha rappresentato la quota maggiore del mercato europeo delle terapie antivirali nel 2019.
Diverse importanti fonti primarie e secondarie associate al rapporto sul mercato delle terapie antivirali in Europa sono l\'Organizzazione mondiale della sanità (OMS), l\'International Trade Administration (ITA), la Federazione europea dei prodotti farmaceutici Industrie e associazioni (EFPIA), Regolamento sanitario internazionale (IHR), Associazione dell\'industria farmaceutica britannica, National AIDS Trusts (NAT) e altri.
Strategic insights for Europe Anti-Viral Therapies involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 11,401.67 Million |
| Market Size by 2027 | US$ 21,122.66 Million |
| Global CAGR (2020 - 2027) | 8.1% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Tipo
|
| Regions and Countries Covered | Europa
|
| Market leaders and key company profiles |
The regional scope of Europe Anti-Viral Therapies refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The List of Companies - Europe Anti-Viral Therapies Market
The Europe Anti-Viral Therapies Market is valued at US$ 11,401.67 Million in 2019, it is projected to reach US$ 21,122.66 Million by 2027.
As per our report Europe Anti-Viral Therapies Market, the market size is valued at US$ 11,401.67 Million in 2019, projecting it to reach US$ 21,122.66 Million by 2027. This translates to a CAGR of approximately 8.1% during the forecast period.
The Europe Anti-Viral Therapies Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Anti-Viral Therapies Market report:
The Europe Anti-Viral Therapies Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Anti-Viral Therapies Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Anti-Viral Therapies Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Anti-Viral Therapies Market
